Illustration: Aïda Amer/Axios

Few things are more valuable in health care than data — specifically prescription data. Surescripts, a company that allows prescriptions to be filled electronically, controls a lot of that data and has every incentive to keep it gated.

Driving the news: Surescripts is asking the FBI to investigate allegations that one of its vendors illegally shared patients' medication histories with Amazon's online pharmacy, PillPack. It's a fight that highlights how difficult it has become for patients to share their own drug data and how incumbent players protect their turf.

How we got here: Surescripts contracted with a reseller called ReMy Health, which gave doctors, hospitals and other prescribers access to data on the drugs patients take or used to take.

Yes, but: Surescripts does not allow pharmacies to access medication history data. That means pharmacists, like those at PillPack, who want to verify someone's prescriptions have to spend the time calling and faxing doctors instead of going directly to Surescripts.

  • Here, Surescripts is alleging ReMy Health was sending that data to PillPack in violation of their contract and that PillPack was requesting data through providers who had never seen its patients.

Background: Surescripts has the backing of powerful players in today's drug supply chain and also has attracted attention for wielding its own market power.

  • Two of the largest pharmacy benefit managers, CVS and Express Scripts, as well as two trade groups representing drug stores own Surescripts.
  • SureScripts is facing a lawsuit from the Federal Trade Commission, which alleges Surescripts violated antitrust law by using its monopoly power to strong-arm pharmacies and other vendors into exclusively using its services.

"This action we are taking is purely and simply about maintaining trust on the network," Surescripts CEO Tom Skelton said in an interview, after being asked about how the firm's monopoly position factored into this dispute.

The other side: ReMy Health did not respond to requests for comment. A PillPack spokesperson said the company's patients give explicit consent to obtain medication histories.

  • "Given that Surescripts is, to our knowledge, the sole clearinghouse for medication history in the United States, the core question is whether Surescripts will allow customers to share their medication history with pharmacies and if not, why not?" PillPack said.

The bottom line: Something as simple as making sure someone is taking the right medications isn't that simple when there are billions of dollars up for grabs.

Go deeper

Scoop: Chinese biotech giant's U.S. subsidiary received PPP loan

Chinese biotech company BGI Genomics provided mobile labs for conducting COVID-19 tests at a sports center in Beijing. Photo credit: Xinhua/Chen Zhonghao via Getty Images.

A U.S. subsidiary of Chinese genomics company BGI Group received a loan through the Paycheck Protection Program (PPP), according to data on the program released by the U.S. Treasury Department this week.

Why it matters: BGI's close ties to the Chinese government, which is constructing a massive genetics database of its population, have raised concerns among U.S. officials.

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 10:30 a.m. ET: 12,077,210 — Total deaths: 550,327 — Total recoveries — 6,636,374Map.
  2. U.S.: Total confirmed cases as of 1o:30 a.m. ET: 3,055,491 — Total deaths: 132,310 — Total recoveries: 953,420 — Total tested: 37,431,666Map.
  3. Public health: Cases rise in 33 states — Fauci says states with severe outbreaks "should seriously look at shutting down"
  4. Education: How Trump's push to reopen schools could backfire — College sports stare down a disaster in the fall.
  5. Jobs: 1.3 million Americans filed for unemployment last week.

Supreme Court says Manhattan prosecutors can obtain Trump's financial records

Photo: Saul Loeb/AFP via Getty Images

The Supreme Court ruled Thursday that Manhattan prosecutors can obtain President Trump's financial records — and punted House Democrats' efforts to access similar records to a lower court.

Why it matters: The Manhattan ruling, a 7-2 decision, is a stinging loss for Trump, who has fought relentlessly to keep these records secret.